 | • レポートコード：D0SP201110 • 出版社/出版日：Transparency Market Research / 2020年9月30日 • レポート形態：英文、PDF、195ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査レポートでは、製薬試験・分析サービスの世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、サービスタイプ別（生物分析試験、方法開発・検証、原材料試験、安定性試験、微生物試験、その他）分析、エンドユーザー別（医療機器会社、製薬およびバイオ医薬品企業、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・市場動向 ・製薬試験・分析サービスの世界市場規模：サービスタイプ別（生物分析試験、方法開発・検証、原材料試験、安定性試験、微生物試験、その他） ・製薬試験・分析サービスの世界市場規模：エンドユーザー別（医療機器会社、製薬およびバイオ医薬品企業、その他） ・製薬試験・分析サービスの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Pharmaceutical Testing and Analytical Services Market – Scope of the Report
TMR’s report on the global pharmaceutical testing and analytical services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global pharmaceutical testing and analytical services market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pharmaceutical testing and analytical services market from 2020 to 2030.
The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical testing and analytical services market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the pharmaceutical testing and analytical services market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global pharmaceutical testing and analytical services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pharmaceutical testing and analytical services market.
The report delves into the competition landscape of the global pharmaceutical testing and analytical services market. Key players operating in the global pharmaceutical testing and analytical services market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pharmaceutical testing and analytical services market profiled in this report.
Key Questions Answered in Pharmaceutical Testing and Analytical Services Market Report
What is the sales/revenue generated by pharmaceutical testing and analytical services across all regions during the forecast period?
What are the opportunities in the global pharmaceutical testing and analytical services market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which service type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Pharmaceutical Testing and Analytical Services Market – Research Objectives and Research Approach
The comprehensive report on the global pharmaceutical testing and analytical services market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global pharmaceutical testing and analytical services market in terms of service type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical testing and analytical services market.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Pharmaceutical Testing and Analytical Services Market Forecast
4.5. Global Pharmaceutical Testing and Analytical Services Market Outlook
5. Market Outlook
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Clinical Trials Analysis
5.3. Covid-19 Impact Analysis
6. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type
6.1. Introduction
6.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
6.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
6.3.1. Bioanalytical Testing
6.3.1.1. Cell-Based Assays
6.3.1.2. Virology Testing
6.3.1.3. Others
6.3.2. Method Development & Validation
6.3.2.1. Extractables & Leachables Method Development & Validation
6.3.2.2. Stability-indicating Method Validation
6.3.2.3. Process Impurity Method Development & Validation
6.3.2.4. Others
6.3.3. Raw Material Testing
6.3.3.1. Heavy Metal Testing
6.3.3.2. Complete Compendial Testing
6.3.3.3. Others
6.3.4. Stability Testing
6.3.4.1. Drug Substance Stability Testing
6.3.4.2. Formulation Evaluation Stability Testing
6.3.4.3. Others
6.3.5. Microbial Testing
6.3.5.1. Microbial Limit Testing
6.3.5.2. Sterility Testing
6.3.5.3. Endotoxin Testing
6.3.5.4. Others
6.3.6. Others
6.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type
7. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user
7.1. Introduction
7.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
7.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
7.3.1. Medical Device Companies
7.3.2. Pharmaceutical & Biopharmaceutical Companies
7.3.3. Others
7.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user
8. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Region
8.1. Global Pharmaceutical Testing and Analytical Services Market Scenario, by Region
8.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Region
8.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
9. North America Pharmaceutical Testing and Analytical Services Market Analysis
9.1. North America Pharmaceutical Testing and Analytical Services Market Overview
9.2. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country
9.3. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Country
9.3.1. U.S.
9.3.2. Canada
9.4. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
9.5. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
9.5.1. Bioanalytical Testing
9.5.1.1. Cell-Based Assays
9.5.1.2. Virology Testing
9.5.1.3. Others
9.5.2. Method Development & Validation
9.5.2.1. Extractables & Leachables Method Development & Validation
9.5.2.2. Stability-indicating Method Validation
9.5.2.3. Process Impurity Method Development & Validation
9.5.2.4. Others
9.5.3. Raw Material Testing
9.5.3.1. Heavy Metal Testing
9.5.3.2. Complete Compendial Testing
9.5.3.3. Others
9.5.4. Stability Testing
9.5.4.1. Drug Substance Stability Testing
9.5.4.2. Formulation Evaluation Stability Testing
9.5.4.3. Others
9.5.5. Microbial Testing
9.5.5.1. Microbial Limit Testing
9.5.5.2. Sterility Testing
9.5.5.3. Endotoxin Testing
9.5.5.4. Others
9.5.6. Others
9.6. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
9.7. North America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
9.7.1. Medical Devices Companies
9.7.2. Pharmaceutical & Biopharmaceutical Companies
9.7.3. Others
10. Europe Pharmaceutical Testing and Analytical Services Market Analysis
10.1. Europe Pharmaceutical Testing and Analytical Services Market Overview
10.2. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
10.3. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
10.5. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
10.5.1. Bioanalytical Testing
10.5.1.1. Cell-Based Assays
10.5.1.2. Virology Testing
10.5.1.3. Others
10.5.2. Method Development & Validation
10.5.2.1. Extractables & Leachables Method Development & Validation
10.5.2.2. Stability-indicating Method Validation
10.5.2.3. Process Impurity Method Development & Validation
10.5.2.4. Others
10.5.3. Raw Material Testing
10.5.3.1. Heavy Metal Testing
10.5.3.2. Complete Compendial Testing
10.5.3.3. Others
10.5.4. Stability Testing
10.5.4.1. Drug Substance Stability Testing
10.5.4.2. Formulation Evaluation Stability Testing
10.5.4.3. Others
10.5.5. Microbial Testing
10.5.5.1. Microbial Limit Testing
10.5.5.2. Sterility Testing
10.5.5.3. Endotoxin Testing
10.5.5.4. Others
10.5.6. Others
10.6. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
10.7. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
10.7.1. Medical Devices Companies
10.7.2. Pharmaceutical & Biopharmaceutical Companies
10.7.3. Others
11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis
11.1. Asia Pacific Pharmaceutical Testing and Analytical Services Market Overview
11.2. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
11.3.1. Japan
11.3.2. China
11.3.3. India
11.3.4. Australia & New Zealand
11.3.5. Rest of Asia Pacific
11.4. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
11.5. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
11.5.1. Bioanalytical Testing
11.5.1.1. Cell-Based Assays
11.5.1.2. Virology Testing
11.5.1.3. Others
11.5.2. Method Development & Validation
11.5.2.1. Extractables & Leachables Method Development & Validation
11.5.2.2. Stability-indicating Method Validation
11.5.2.3. Process Impurity Method Development & Validation
11.5.2.4. Others
11.5.3. Raw Material Testing
11.5.3.1. Heavy Metal Testing
11.5.3.2. Complete Compendial Testing
11.5.3.3. Others
11.5.4. Stability Testing
11.5.4.1. Drug Substance Stability Testing
11.5.4.2. Formulation Evaluation Stability Testing
11.5.4.3. Others
11.5.5. Microbial Testing
11.5.5.1. Microbial Limit Testing
11.5.5.2. Sterility Testing
11.5.5.3. Endotoxin Testing
11.5.5.4. Others
11.5.6. Others
11.6. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
11.7. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
11.7.1. Medical Devices Companies
11.7.2. Pharmaceutical & Biopharmaceutical Companies
11.7.3. Others
12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis
12.1. Latin America Pharmaceutical Testing and Analytical Services Market Overview
12.2. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
12.5. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
12.5.1. Bioanalytical Testing
12.5.1.1. Cell-Based Assays
12.5.1.2. Virology Testing
12.5.1.3. Others
12.5.2. Method Development & Validation
12.5.2.1. Extractables & Leachables Method Development & Validation
12.5.2.2. Stability-indicating Method Validation
12.5.2.3. Process Impurity Method Development & Validation
12.5.2.4. Others
12.5.3. Raw Material Testing
12.5.3.1. Heavy Metal Testing
12.5.3.2. Complete Compendial Testing
12.5.3.3. Others
12.5.4. Stability Testing
12.5.4.1. Drug Substance Stability Testing
12.5.4.2. Formulation Evaluation Stability Testing
12.5.4.3. Others
12.5.5. Microbial Testing
12.5.5.1. Microbial Limit Testing
12.5.5.2. Sterility Testing
12.5.5.3. Endotoxin Testing
12.5.5.4. Others
12.5.6. Others
12.6. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
12.7. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
12.7.1. Medical Devices Companies
12.7.2. Pharmaceutical & Biopharmaceutical Companies
12.7.3. Others
13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis
13.1. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Overview
13.2. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of Middle East & Africa
13.4. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
13.5. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
13.5.1. Bioanalytical Testing
13.5.1.1. Cell-Based Assays
13.5.1.2. Virology Testing
13.5.1.3. Others
13.5.2. Method Development & Validation
13.5.2.1. Extractables & Leachables Method Development & Validation
13.5.2.2. Stability-indicating Method Validation
13.5.2.3. Process Impurity Method Development & Validation
13.5.2.4. Others
13.5.3. Raw Material Testing
13.5.3.1. Heavy Metal Testing
13.5.3.2. Complete Compendial Testing
13.5.3.3. Others
13.5.4. Stability Testing
13.5.4.1. Drug Substance Stability Testing
13.5.4.2. Formulation Evaluation Stability Testing
13.5.4.3. Others
13.5.5. Microbial Testing
13.5.5.1. Microbial Limit Testing
13.5.5.2. Sterility Testing
13.5.5.3. Endotoxin Testing
13.5.5.4. Others
13.5.6. Others
13.6. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
13.7. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
13.7.1. Medical Devices Companies
13.7.2. Pharmaceutical & Biopharmaceutical Companies
13.7.3. Others
14. Competitive Landscape
14.1. Competition Matrix
14.2. Global Pharmaceutical Testing and Analytical Services Market Share Analysis, by Company
14.3. Company Profile
14.3.1. Eurofins Scientific
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Laboratory Corporation of America Holdings
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. SGS S.A
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Intertek Group plc
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. RD Laboratories, Inc
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. WuXi AppTec Co., Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. DYNALABS LLC (Infinity Laboratories)
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. ARL Bio Pharma
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
Purchase Options
Single User License $5795
Multi-User License $8795
Corporate License $11795
Buy Now
Related Reports
Genetic Disease Diagnostic Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024
Drug Adherence Enhancement Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027
Curved Tip Serrated Forceps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
Medical Grade Gels Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Breastfeeding Accessories Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Plate Sealer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026
Dental Mirror Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026
Stool Management Systems Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2027
Contralateral Routing of Signals Hearing Aid Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2026
Carbohydrase Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024
Audiology Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020 – 2030
Neurology Endoscopy Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
Mucosal Atomization Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Dural Sealants Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014- 2020
Special Purpose Needles Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Custom Market Resear
Table 01: Epidemiology of COVID-19 Country/Sub-region
Table 02: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 03: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 04: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 05: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 06: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 07: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 08: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 09: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 10: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 11: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 12: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 13: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 14: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 15: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 16: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 17: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 18: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 19: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 20: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 21: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 22: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 23: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 24: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 25: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 26: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 27: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 28: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 29: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 30: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 31: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 32: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 33: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 34: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 35: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 36: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 37: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 38: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 39: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 40: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 41: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 42: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 43: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 44: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 45: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 46: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 47: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 48: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 49: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030